1. Dr. Heather F. Pidcoke joins Cellphire, Inc. as Chief Medical Officer

    March 1, 2018 — Cellphire, Inc., the global leader in long-term stabilization and storage of platelets and other cells, announced today that Heather Pidcoke, MD, MSCI, Ph.D., has joined the company as Chief Medical Officer. Dr. Pidcoke’s translational research interests include trauma critical care and novel transfusion products aimed at improving the resuscitation of massively bleeding patients.Prior […]


  2. BodeVet – Elephant Disease Causes Death by Hemorrhage… Lyophilized Platelets May Help

    February 1, 2018 — Cellphire, Inc., the global leader in long-term stabilization and storage of platelets and other cells, announced today that the in-human care population of elephants is plagued by an endotheliotropic herpes virus that attacks young elephants and causes an acute loss of platelets with associated bleeding. BodeVet, Inc. working with the Smithsonian Institute […]


  3. Cellphire Investors Again Receive 50% Maryland Biotechnology Investment Incentive Tax Credit

    (November 2017) Cellphire, Inc. announced today that investors who participated in the $3,000,000 Cellphire funding round that closed in June have received their Final Tax Credit Certificates from the Maryland Department of Commerce awarding them a 50 percent refundable tax credit for their investments in Cellphire. They are now able to claim the tax refund by […]


  4. BodeVet Chief Technical Officer to Present at IVECCS 2017

    BodeVet Chief Technical Officer, Anne Hale, CVM, will advise on controversies in blood banking at the International Veterinary Emergency and Critical Care Symposium, (IVECCS) 2017 in Nashville, Tennessee. As a recognized world leader in veterinary blood banking, Dr. Hale joins a select panel of experts for a discussion of veterinary blood banking challenges. This discussion […]


  5. Cellphire Awarded Grant to Develop Elephant Endotheliotropic Herpesvirus (EEHV) Freeze Platelet Treatment

    Thanks to a grant from the International Elephant Foundation, Cellphire, Smithsonian Global Health Program, Ringling Bros. Center for Elephant Conservation, Fort Worth Zoo and Houston Zoo have made great strides in developing a novel treatment for a lethal virus afflicting baby Asian elephants around the globe. Elephant Endotheliotropic Herpesvirus (EEHV) is the leading cause of […]


  6. Cellphire Closes $3,000,000 Funding Round

    Cellphire, Inc. announced today that it had closed a $3,000,000.00 funding round, with investments from both new investors and exisiting investors, management, and the board of directors.”The additional capital will augment the $69 million commitment from BARDA [The Biomedical Advanced Research and Development Authority],” said CEO Stephen Willard, “and enables us to initiate the commercial […]


  7. Dr. David Hirsh Joins Cellphire, Inc. Board of Directors

    (April 2017) Cellphire, Inc. announced today that David I. Hirsh, Ph.D. has joined the Company’s Board of Directors.  Dr. Hirsh is a Professor in the Department of Biochemistry and Molecular Biophysics at the College of Physicians and Surgeons of Columbia University. He has served as Chairman of the Department and as Executive Vice President of Research […]


  8. Dr. Anne Hale, DVM Joins BodeVet as Chief Technical Officer

    (April 2017) Cellphire, Inc. announced that Anne Hale, DVM has joined its veterinary subsidiary BodeVet, Inc. as its Chief Technical Officer. Dr. Hale is a renowned expert in veterinary transfusion medicine. Dr. Hale has a strong academic track record and has received a NIH Comparative Fellowship in Transfusion Medicine. Dr. Hale founded and guided Midwest […]


  9. BodeVet – StablePlate RX® Launching in September at IVECCS 2017

    (March 2017) This September, the world’s first infusible freeze-dried platelet-derived product will be StablePlate RX for canines. StablePlate RX is a shelf-stable hemostatic agent that couples the healing of hemostatic power of platelets with the stability and convenience of other medicines. BodeVet will release StablePlate RX on a limited basis at the International Veterinary and […]


  10. Rafael Jorda Joins Cellphire, Inc. as Vice President of R&D

    (January 2017) Cellphire, Inc. announced today that Rafael Jorda has joined the company as Vice President of Research & Development.  Mr. Jorda is an internationally experienced scientific leader with more than 25 years of experience in private and public company management spanning three continents. He has managed the R&D, Intellectual Property, Production, and Business Development […]